Literature DB >> 29879438

Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice.

Alexia V Williams1, Abigail Laman-Maharg2, Crystal V Armstrong1, Stephanie Ramos-Maciel1, Vanessa A Minie1, Brian C Trainor3.   

Abstract

Kappa opioid receptors (KOR) are considered to be a promising therapeutic target for stress-induced psychiatric disorders such as anxiety and depression. Preclinical data show that KOR antagonists have greater efficacy if administered before stressful experiences as opposed to afterwards. However, almost all of these studies use long-acting antagonists, leaving it unclear whether inhibition of KOR after stress is required for efficacy. Here we show that administration of the short-acting KOR antagonist AZ-MTAB before episodes of social defeat stress block the induction of anhedonia (both males and females) and social avoidance responses (females) that persist two weeks after stress. In both males and females pre-stress AZ-MTAB treatment also blunted anticipatory autogrooming behavior immediately prior to the third episode of defeat. In contrast when AZ-MTAB was administered two weeks after defeat (immediately before behavior testing) in female California mice, it was ineffective at reversing anhedonia and social avoidance. These results suggest that short-acting KOR antagonists may have greater therapeutic potential if administered before exposure to psychosocial stressors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anhedonia; Depression; Kappa opioid receptor; Social defeat stress; Social interaction

Mesh:

Substances:

Year:  2018        PMID: 29879438      PMCID: PMC6054130          DOI: 10.1016/j.pnpbp.2018.06.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  48 in total

1.  Social defeat stress induces a depression-like phenotype in adolescent male c57BL/6 mice.

Authors:  Sergio D Iñiguez; Lace M Riggs; Steven J Nieto; Genesis Dayrit; Norma N Zamora; Kristi L Shawhan; Bryan Cruz; Brandon L Warren
Journal:  Stress       Date:  2014-05       Impact factor: 3.493

2.  Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.

Authors:  Patrick M Beardsley; James L Howard; Keith L Shelton; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

3.  "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".

Authors:  Marta Valenza; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2017-05-27       Impact factor: 4.530

4.  Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.

Authors:  Vincent Castagné; Paul Moser; Sylvain Roux; Roger D Porsolt
Journal:  Curr Protoc Neurosci       Date:  2011-04

5.  Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.

Authors:  Allison T Knoll; Edward G Meloni; James B Thomas; F Ivy Carroll; William A Carlezon
Journal:  J Pharmacol Exp Ther       Date:  2007-09-06       Impact factor: 4.030

6.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

7.  Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.

Authors:  Amanda N Carey; Angela M Lyons; Christopher F Shay; Ocean Dunton; Jay P McLaughlin
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

8.  A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.

Authors:  Jeffrey J Buda; F I Carroll; Thomas R Kosten; Dennis Swearingen; Bradford B Walters
Journal:  Neuropsychopharmacology       Date:  2015-01-23       Impact factor: 7.853

Review 9.  Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Authors:  Elena H Chartoff; Maria Mavrikaki
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

10.  Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine.

Authors:  Caroline A Browne; Edgardo Falcon; Shivon A Robinson; Olivier Berton; Irwin Lucki
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

View more
  15 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

Review 2.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

3.  Impact of Pharmacological Manipulation of the κ-Opioid Receptor System on Self-grooming and Anhedonic-like Behaviors in Male Mice.

Authors:  Eduardo R Butelman; Bryan D McElroy; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2019-04-11       Impact factor: 4.030

Review 4.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

5.  Extrahypothalamic oxytocin neurons drive stress-induced social vigilance and avoidance.

Authors:  Natalia Duque-Wilckens; Lisette Y Torres; Sae Yokoyama; Vanessa A Minie; Amy M Tran; Stela P Petkova; Rebecca Hao; Stephanie Ramos-Maciel; Roberto A Rios; Kenneth Jackson; Francisco J Flores-Ramirez; Israel Garcia-Carachure; Patricia A Pesavento; Sergio D Iñiguez; Valery Grinevich; Brian C Trainor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

6.  Anxious to see you: Neuroendocrine mechanisms of social vigilance and anxiety during adolescence.

Authors:  Emily C Wright; Camelia E Hostinar; Brian C Trainor
Journal:  Eur J Neurosci       Date:  2019-12-20       Impact factor: 3.386

7.  The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2020-09-07       Impact factor: 4.530

8.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Convergent neuroendocrine mechanisms of social buffering and stress contagion.

Authors:  Natanja F Peen; Natalia Duque-Wilckens; Brian C Trainor
Journal:  Horm Behav       Date:  2021-01-20       Impact factor: 3.587

10.  Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress.

Authors:  Gui-Ying Zan; Xiang Sun; Yu-Jun Wang; Rui Liu; Chen-Yao Wang; Wei-Jia Du; Liu-Bin Guo; Jing-Rui Chai; Qing-Lin Li; Zhi-Qiang Liu; Jing-Gen Liu
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.